title: Does hyperprolactinaemia predispose to aluminium toxicity in chronic renal failure?
authors.affiliation: Renal Unit, Lister Hospital, Stevenage, Herts, UK.
authors.forename: T
authors.initials: T
authors.lastname: Corbett
authors.forename: D
authors.initials: D
authors.lastname: de Takats
authors.forename: J E
authors.initials: JE
authors.lastname: Tattersall
authors.forename: R N
authors.initials: RN
authors.lastname: Greenwood
authors.forename: K
authors.initials: K
authors.lastname: Farrington
mesh_terms: D000328:Adult; D000535:Aluminum / Q000009:adverse effects* / Q000097:blood; D003928:Diabetic Nephropathies / Q000097:blood / Q000150:complications; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000097:blood / Q000150:complications* / Q000209:etiology; D007408:Intestinal Absorption; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications*; D008750:Methyldopa / Q000009:adverse effects; D008787:Metoclopramide / Q000009:adverse effects; D008875:Middle Aged; D011388:Prolactin / Q000097:blood
chemical_list: D008750:Methyldopa; D011388:Prolactin; D000535:Aluminum; D008787:Metoclopramide